NunaBio is awarded ISO9001 certification
NunaBio is proud to announce our successful certification to ISO 9001:2015, an internationally recognised Quality Management Standard which ensures...
09 May 2022
NunaBio’s patented technology is used to manufacture unique, high quality designer DNA products.
Our short turnaround times will save you time and money and all of our products are quality assured and manufactured under ISO9001 guidelines. As well as providing off-the-shelf sequences, we can also work with you to create custom designs including modifications and sequence lengths up to 40kb. Ordering from our online store is quick and simple - click on Products and Technologies to find out more.
We continually invest in our technology, facilities and personnel to ensure we are constantly evolving to meet the changing needs of our clients' marketplace. Click on Demand-Led Innovation for more information about our current research and development projects.
Working with NunaBio
We work through detail design, integration and initial testing, repeating this process to optimise the design before verification testing.
Our work is fully documented and a package of data and specifications can be assembled to allow scale up manufacture to start smoothly.
We have extensive experience in Process Validation, Project Management to Phase 2 Manufacturing Criteria, Change Management and Quality Assurance to Regulatory standards (MHRA; FDA).
Our operations management is led by a Lead Auditor qualified in Quality Management (ISO9001), Medical Devices (ISO13485), Laboratory Testing (ISO17025), Information Security (ISO27001), and Environmental Management (ISO14001).
Latest News
NunaBio is awarded ISO9001 certification
09 May 2022
NunaBio demonstrates a novel technology for confirming the presence of E. coli
07 July 2021
NunaBio demonstrates sensing technology that could predict a predisposition to colorectal cancer
20 May 2021
NunaBio Manufactures Unique DNA
04 May 2021
NunaBio Develops Enhanced Sensing Technology
29 April 2021
NunaBio Completes Seed Funding
22 April 2021